{
  "pmcid": "5547920",
  "sha256": "28129a267ed2275d62c6db63dc9873044bc6f26022c53b426e632613b2d6e034",
  "timestamp_utc": "2025-11-09T16:04:25.153954+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 11.670217391304348,
    "reading_ease": 36.60254180602007,
    "word_count": 368
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Patients were randomly assigned to receive follow-up care via a mobile app or at an in-person visit during the first 30 days after the operation."
      },
      "Participants": {
        "score": 2,
        "evidence": "among ambulatory patients undergoing breast reconstruction at an academic ambulatory care hospital."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Patients were randomly assigned to receive follow-up care via a mobile app or at an in-person visit during the first 30 days after the operation."
      },
      "Objective": {
        "score": 1,
        "evidence": "Objective: To determine whether follow-up care delivered via a mobile app can be used to avert in-person follow-up care visits compared with conventional, in-person follow-up care in the first 30 days following ambulatory surgery."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary end point was the number of in-person follow-up visits during the first 30 days after the operation."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Patients were randomly assigned to receive follow-up care via a mobile app or at an in-person visit during the first 30 days after the operation."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Of the 65 women in the study (mean [SD] age, 47.7 [13.4] years), 32 (49%) were in the mobile app group, and 33 (51%) were in the in-person follow-up care group."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Analysis was intention-to-treat."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Those in the mobile app group attended a mean of 0.66 in-person visits, vs 1.64 in-person visits in the in-person follow-up care group, for a difference of 0.40 times fewer in-person visits (95% CI, 0.24-0.66; P <â€‰.001)"
      },
      "Harms": {
        "score": 1,
        "evidence": "There was no difference between groups in the number of telephone communications, satisfaction scores, or complication rates."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial Registration: clinicaltrials.gov Identifier: NCT02318953"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 16,
    "max_score": 25
  }
}